Contract Services Contract Manufacturing
WuXiUI™ ultra-intensified fed-batch platform offers a new process option for maximum flexibility to meet various clients' needs in biologics d...
October 17, 2023 | News
Coriolis Pharma secures investment from KKR to support next steps in growth and to expand global footprint Newly formed KKR platform Frontier Biosolutio...
October 16, 2023 | News
Sysmex has built up a robust technological foundation as well as a global network in the in vitro diagnostics field through developing its busine...
October 11, 2023 | News
Construction of a Bio Plant with a total production capacity of 360 kL at Songdo's Block KI20, Zone 11 by 2030 Aims to secure capabilities of an interna...
October 05, 2023 | News
Pombiliti™, a recombinant human GAA enzyme (rhGAA) naturally expressed with high levels of bis-M6P (Mannose 6-Phosphate), was started at WuXi Biologi...
October 02, 2023 | News
The launch of the new base in Shanghai will enhance OBiO's production and service capabilities in both China and the United States...
September 28, 2023 | News
The opening will add drug substance and drug product capacity, with end-to-end services for diversified vaccines that will accelerate global clients' proje...
September 27, 2023 | News
New sites at Darmstadt and Hamburg complement Merck’s global integrated mRNA service network with pre-clinical to commercial capabilities Company&...
September 27, 2023 | News
Chime Biologics, a leading CDMO that enables its partners' success in biologics, announced a strategic cooperation with Kings Pharm. According to the agre...
September 26, 2023 | News
Chime Biologics, a leading CDMO that enables biologic therapeutics development announced a strategic cooperation agreement with Panolos Bioscience, a South...
September 25, 2023 | News
New commercial facilities offer one-stop manufacturing services for antibody intermediates, bioconjugate drug substance and drug product Do...
September 21, 2023 | News
To diversify its operational scope, the new facility will be designed to accommodate different scales of production. Initially, it will introduce three new...
September 19, 2023 | News
Bristol Myers Squibb and Samsung Biologics have an existing manufacturing agreement for a commercial antibody cancer drug and have expanded the s...
September 18, 2023 | News
Most Read
Bio Jobs
News
Editor Picks